New painkiller may ease wisdom tooth recovery better than standard option
NCT ID NCT06547255
First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times
Summary
This study tested whether a long-acting painkiller called Exparel works better than standard bupivacaine for pain after removing all four wisdom teeth. 82 adults took part and reported their pain and side effects for four days after surgery. The goal was to see which drug provides better pain relief and reduces the need for extra pain pills.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIPOSOMAL BUPIVACAINE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Case Western Reserve University
Cleveland, Ohio, 44106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Wrist surgery pain relief showdown: which block works best?
- New pain block could keep hip surgery patients comfortable for days
- New pain block could cut opioid use after lung transplants
- New painkiller may offer longer relief after gallbladder surgery
- New pain block could speed recovery after lung surgery
- Knee replacement pain relief showdown: which numbing cocktail wins?